Patients may end up with drugs that "may not be effective at all" if doctors were made to prescribe only generic medicines as indicated by Prime Minister Narendra Modi, according to pharma industry body IPA.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

The Indian Pharmaceutical Alliance (IPA) said that due to the nature of the current off-patent medicines market in India, if such a step were to be followed, the choice of products will be shifted from doctors to chemists, not patients.

Elaborating on the challenges, IPA Secretary General IPA told

(This article has not been edited by DNA's editorial team and is auto-generated from an agency feed.)